Orphazyme launches investigation into dramatic and mysterious share price roller coaster
Orphazyme experienced significant turbulence on the US market on Thursday, where share price increases peaked at 1,400 percent with no explanation or forewarning. This rubbed off on the Danish exchange on Friday.
BY JENS ERIK RASMUSSEN, TRANSLATED BY NIELSINE NIELSEN
Prices of shares in biotech company Orphazyme have been through an inexplicable roller coaster since Thursday.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
.jpg&w=384&q=75)
